Journal article · 2022 · Open access
Application of Patient-Reported Outcome Measurements in Clinical Trials in China
JAMA Network Open, 5(5), e2211644 · Published 11 May 2022 · DOI 10.1001/jamanetworkopen.2022.11644
In brief
“Application of Patient-Reported Outcome Measurements in Clinical Trials in China” is a 2022 journal article by Hui Zhou and 9 co-authors, published in JAMA Network Open. OpenAlex counts 31 citations as of 22 November 2026. It is open access under a CC BY licence: the full text is free to read at JAMA Network Open.
- Citations
- 31
- Most cited in
- 2025 (12)
- Field-weighted impact
- 2.82
- References
- 44
- Authors
- 10
Abstract
Importance: Regulatory authorities, industry peers, and international health policies have emphasized the value of assessing patient-reported outcomes (PROs) in clinical studies. Despite the increase in the number of clinical studies in the last decade in China, little is known about the extent of the use of PROs. Objective: To evaluate the application and characteristics of PRO instruments as primary and secondary outcomes in randomized clinical trials in China. Design, Setting, and Participants: A cross-sectional study of interventional clinical trials conducted in China from January 1, 2010, to December 31, 2020, was performed. Data obtained from the Chinese Clinical Trial Registry and ClinicalTrials.gov databases were evaluated. Main Outcomes and Measures: Trials were categorized according to those that (1) precisely listed PRO tools as outcomes, (2) mentioned patient subjective feelings in outcomes but did not clarify which tools were used for assessment, and (3) did not mention any PRO measurements. Data on study phase, setting, participant age, and sex were extracted from trials that considered patient feelings, along with the target diseases and names of the PRO tools. Results: Among a total of 34 033 trials, 6915 (20.3%) listed the explicit PRO instruments used and 3178 (9.3%) included PRO in their outcomes but did not include the names of the assessment tools. From more than 32 million people included in the registered trials, data on 1.5 million (4.7%) patients were scientifically collected by PRO instruments, and subjective feelings were assessed for 693 867 (2.1%) participants. Pain (16.8%), cancer (15.6%), and musculoskeletal symptoms (13.3%) were the most common conditions for which PROs were precisely collected by tools. The most common tools for PRO measurements were the visual analog scale, Short-Form 36, and Hamilton Depression Scale. Conclusions and Relevance: In this cross-sectional study, the use of PROs increased during the study period in clinical trials conducted in China. However, patient opinion appears to still be rarely measured. The application of PRO is geographically unevenly distributed. Development of PRO instruments, especially those suitable for the Chinese population, may be useful. Further expansion of PROs with respect to the scope of diseases is needed to avoid missing important data.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Zhou, H., Yao, M., Gu, X., Liu, M., Zeng, R., Li, Q., Chen, T., He, W., Chen, X., & Yuan, G. (2022). Application of Patient-Reported Outcome Measurements in Clinical Trials in China. JAMA Network Open, 5(5), e2211644. https://doi.org/10.1001/jamanetworkopen.2022.11644
MLA 9
Zhou, Hui, et al. “Application of Patient-Reported Outcome Measurements in Clinical Trials in China.” JAMA Network Open, vol. 5, no. 5, 2022, p. e2211644. https://doi.org/10.1001/jamanetworkopen.2022.11644.
Chicago
Zhou, Hui, Mi Yao, Xiaodan Gu, Mingrui Liu, Ruifeng Zeng, Qin Li, Tingjia Chen, Wen He, Xiao Chen, and Gang Yuan. 2022. “Application of Patient-Reported Outcome Measurements in Clinical Trials in China.” JAMA Network Open 5 (5): e2211644. https://doi.org/10.1001/jamanetworkopen.2022.11644.
Harvard
Zhou, H. et al. (2022) ‘Application of Patient-Reported Outcome Measurements in Clinical Trials in China’, JAMA Network Open, 5(5), p. e2211644. doi:10.1001/jamanetworkopen.2022.11644.
IEEE
H. Zhou et al., “Application of Patient-Reported Outcome Measurements in Clinical Trials in China,” JAMA Network Open, vol. 5, no. 5, p. e2211644, 2022, doi: 10.1001/jamanetworkopen.2022.11644.
BibTeX
@article{zhou2022application,
title = {{Application of Patient-Reported Outcome Measurements in Clinical Trials in China}},
author = {Zhou, Hui and Yao, Mi and Gu, Xiaodan and Liu, Mingrui and Zeng, Ruifeng and Li, Qin and Chen, Tingjia and He, Wen and Chen, Xiao and Yuan, Gang},
journal = {JAMA Network Open},
year = {2022},
volume = {5},
number = {5},
pages = {e2211644},
doi = {10.1001/jamanetworkopen.2022.11644},
url = {https://doi.org/10.1001/jamanetworkopen.2022.11644}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2022 | 1 | |
| 2023 | 3 | |
| 2024 | 6 | |
| 2025 | 12 | |
| 2026 | 9 |
Its field-weighted citation impact is 2.82: it has been cited 2.82 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- patient-reported outcomes
- randomized controlled trials
- China
- clinical trial registries
- primary and secondary outcomes
- pain
- cancer
- musculoskeletal symptoms
Work with this paper
Most-cited papers in Mathematics
- Random ForestsLeo Breiman · Machine Learning · 2001 · 142,830 citations
- Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple TestingYoav Benjamini, Yosef Hochberg · Journal of the Royal Statistical Society Series B (Statistical Methodology) · 1995 · 113,923 citations
- Fitting Linear Mixed-Effects Models Using lme4Douglas M. Bates, Martin Maechler, Benjamin M. Bolker and 1 more · Journal of Statistical Software · 2015 · 100,328 citations
- The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations.Reuben M. Baron, David A. Kenny · Journal of Personality and Social Psychology · 1986 · 95,866 citations
- Using multivariate statisticsBarbara Gerson Tabachnick, Linda S. Fidell · 1983 · 79,867 citations
Questions about this paper
How do I cite this paper in APA style?
Zhou, H., Yao, M., Gu, X., Liu, M., Zeng, R., Li, Q., Chen, T., He, W., Chen, X., & Yuan, G. (2022). Application of Patient-Reported Outcome Measurements in Clinical Trials in China. JAMA Network Open, 5(5), e2211644. https://doi.org/10.1001/jamanetworkopen.2022.11644
How many times has this paper been cited?
31 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at JAMA Network Open: sign in and open the PDF from this page.
Who wrote this paper?
Hui Zhou, Mi Yao, Xiaodan Gu, Mingrui Liu, Ruifeng Zeng, Qin Li, Tingjia Chen, Wen He, Xiao Chen, Gang Yuan.
What is the DOI of this paper?
10.1001/jamanetworkopen.2022.11644, permanently at https://doi.org/10.1001/jamanetworkopen.2022.11644. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.